Skip to main content
Figure 1 | BMC Immunology

Figure 1

From: Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM

Figure 1

EpCAM expression is associated with the proliferation and metastatic potential of PC3 cells. A) The proliferation rates of EpCAM+, EpCAM−, and unsorted PC3 cells were determined with a CCK-8 assay. Statistical analysis was performed using a two-way ANOVA. B) The expression of EpCAM on PC3 and PC3M cells was determined by staining the cells with a PE-conjugated anti-EpCAM antibody.

Back to article page